Data / Drug companies / Clobazam
Clobazam: 18 companies and 36 products in the FDA NDC directory
Clobazam is listed in the FDA National Drug Code Directory by 18 companies, with 36 products in commercial distribution. 30 of the products (83.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; suspension; film, and the newest product started marketing on March 10, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 18
- Products
- 36
- Generic (ANDA) products
- 30 (83.3%)
- Application numbers
- 17
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- Brand names
- Onfi, Sympazan
- openFDA record search
- api.fda.gov
Companies that list clobazam
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ascend Laboratories, LLC | 4 | tablet; suspension | Generic drugs (ANDA) | October 18, 2023 |
| Amneal Pharmaceuticals NY LLC | 3 | tablet; suspension | Generic drugs (ANDA) | October 22, 2018 |
| Aquestive Therapeutics | 3 | film | New drug applications (NDA) | November 1, 2018 |
| Camber Pharmaceuticals, Inc. | 3 | tablet; suspension | Generic drugs (ANDA) | February 24, 2020 |
| Lundbeck Pharmaceuticals LLC | 3 | tablet; suspension | New drug applications (NDA) | December 10, 2013 |
| NorthStar Rx LLC | 3 | tablet; suspension | Generic drugs (ANDA) | May 1, 2020 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | October 22, 2018 |
| Lupin Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 8, 2019 |
| Micro Labs Limited | 2 | tablet | Generic drugs (ANDA) | April 2, 2019 |
| Novadoz Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | June 10, 2022 |
| Upsher-Smith Laboratories, LLC | 2 | tablet | Generic drugs (ANDA) | October 22, 2018 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | January 17, 2019 |
| Aurobindo Pharma Limited | 1 | suspension | Generic drugs (ANDA) | March 24, 2022 |
| Bionpharma Inc. | 1 | suspension | Generic drugs (ANDA) | October 20, 2017 |
| Bryant Ranch Prepack | 1 | suspension | Generic drugs (ANDA) | March 24, 2022 |
| Chartwell RX, LLC | 1 | suspension | Generic drugs (ANDA) | April 24, 2020 |
| Precision Dose, Inc. | 1 | suspension | Generic drugs (ANDA) | March 10, 2025 |
| Sun Pharmaceutical Industries, Inc. | 1 | suspension | Generic drugs (ANDA) | June 30, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 22 | 61.1% |
| Suspension | 11 | 30.6% |
| Film | 3 | 8.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 30 | 83.3% |
| New drug applications (NDA) | 6 | 16.7% |
Pharmacologic classes
| Class | Products |
|---|---|
| Benzodiazepine | 36 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.